University of California Irvine Division of Hematology-Oncology, Department of Medicine UC Irvine Health is a clinical research site located in Orange, California, United States 92868.
Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.
University of California Irvine Division of Hematology-Oncology, Department of Medicine UC Irvine Health has participated in 1 clinical trials.
Therapeutic areas: Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic.
Sponsors: Halozyme Therapeutics.
Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of California Irvine Division of Hematology-Oncology, Department of Medicine UC Irvine Health has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of California Irvine Division of Hematology-Oncology, Department of Medicine UC Irvine Health has 1 clinical trials on record. Their work covers Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic.
University of California Irvine Division of Hematology-Oncology, Department of Medicine UC Irvine Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.